Cases
Cases 21 - 30 of 1,745
IVERS v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2023cv21150
Plaintiff: ANTHONY IVERS
Defendant: ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., ARROW PHARM (MALTA) LTD., TEVA PHARMACEUTICAL INDUSTRIES, LTD. and others
In Re: VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
AXSOME MALTA LTD. et al v. ALKEM LABORATORIES LTD. et al
as 2:2023cv20354
Plaintiff: AXSOME MALTA LTD. and AXSOME THERAPEUTICS, INC.
Defendant: ALKEM LABORATORIES LTD., AUROBINDO PHARMA USA, INC., HETERO USA INC. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Louisiana Health Service & Indemnity Company et al v. Celgene Corporation et al We have downloadable decisions or orders for this case
as 1:2023cv07871
Plaintiff: Louisiana Health Service & Indemnity Company individually and on behalf of all others similarly situated doing business as Blue Cross and Blue Shield of Louisiana and HMO Louisiana, Inc.
Defendant: Celgene Corporation, Bristol Myers Squibb Company, Aurobindo Pharma Limited and others
Cause Of Action: 15 U.S.C. § 1 Antitrust Litigation (Monopolizing Trade)
ANDERSON et al v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv13680
Plaintiff: JERRY ANDERSON and PHILISA J. ANDERSON
Defendant: AUROBINDO PHARMA, LTD., AUROLIFE PHARMA, LLC, AUROBINDO PHARMA USA, INC. and others
In Re: VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
KENNEDY v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2023cv13282
Plaintiff: ROBERT KENNEDY
Defendant: ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD, AUROBINDO PHARMA, LTD., AUROLIFE PHARMA, LLC and others
In Re: VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALITIES LTD. et al
as 1:2023cv06667
Plaintiff: THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA IRELAND LIMITED and others
Defendant: EUGIA PHARMA SPECIALITIES LTD., EUGIA US LLC, AUROBINDO PHARMA USA, INC. and others
Counter Claimant: LUPIN INC.
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
WOJNICKI v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv04496
Plaintiff: JAMES WOJNICKI
Defendant: AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re: VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Vifor Fresenius Medical Care Renal Pharma Ltd. et al v. Aurobindo Pharma Ltd. et al
as 1:2023cv00877
Plaintiff: Vifor Fresenius Medical Care Renal Pharma Ltd. and Vifor Fresenius Medical Care Renal Pharma France S.A.S.
Defendant: Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Merck Sharp & Dohme B.V. v. Aurobindo Pharma USA, Inc.
as 23-2254
Plaintiff / Appellee: MERCK SHARP & DOHME B.V. and MERCK SHARP & DOHME, LLC
Defendant / Appellant: AUROBINDO PHARMA USA, INC., AUROBINDO PHARMA LTD., USV PRIVATE LIMITED and others
Defendant: LUPIN LTD., LUPIN PHARMACEUTICALS, INC. and LUPIN INC.
SHANNON et al v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv04229
Plaintiff: STANLEY SHANNON and NELLIE F. LAWLER-SHANNON
Defendant: AUROBINDO PHARMA, LTD., MYLAN LABORATORIES, LTD., MYLAN N.V. and others
In Re: VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?